Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Plos One|October 28, 2016
Transcriptional Profiling of Egg Allergy and Relationship to Disease PhenotypeRoman Kosoy, Charuta Agashe, Alexander Grishin, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2020
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergyEdwin H Kim, Tamara T Perry, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2016
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapyStacie M Jones, A Wesley Burks, Corinne Keet, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2021
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohortsM Cecilia Berin, Charuta Agashe, A Wesley Burks, et al.
Transplantation and Cellular Therapy|July 15, 2022
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 TrialQaiser Bashir, Taiga Nishihori, Marcelo C Pasquini, et al.
Blood|January 21, 2021
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trialEphraim J Fuchs, Paul V O'Donnell, Mary Eapen, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy ResearchAmy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2017
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adultsStacie M Jones, Scott H Sicherer, A Wesley Burks, et al.
Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.
Transplantation and Cellular Therapy|April 7, 2022
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012Claudio G Brunstein, Paul V O'Donnell, Brent Logan, et al.
Pageof 11